GPC3 and cancer: The changes in gene expression can range from over expression of native proteins (e.g. Epidermal Growth Factor Receptor (EGFR), Survivin), mutated proteins (e.g. p53) to reactivation of oncofetal proteins (e.g. AFP, Glypican 3 (GPC3)) resulting in phenotypic as well as the genotypic changes in the cancer.